Portal de Periódicos da CAPES

AGING, ATHEROSCLEROSIS AND ASCORBIC ACID METABOLISM*

1966; Wiley; Volume: 14; Issue: 12 Linguagem: Inglês

10.1111/j.1532-5415.1966.tb02925.x

1532-5415

Boris Sokoloff, Michiteru Hori, Clarence C. Saelhof, Teresa Wrzolek, Tomie Imai,

Alcoholism and Thiamine Deficiency

Journal of the American Geriatrics SocietyVolume 14, Issue 12 p. 1239-1260 Article AGING, ATHEROSCLEROSIS AND ASCORBIC ACID METABOLISM* Boris Sokoloff M.D., Ph.D., Boris Sokoloff M.D., Ph.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaDirector.Search for more papers by this authorMichiteru Hori M.D., Michiteru Hori M.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this authorClarence C. Saelhof M.D., Ph.D., Clarence C. Saelhof M.D., Ph.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this authorTeresa Wrzolek M.D., Teresa Wrzolek M.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this authorTomie Imai B.S., Tomie Imai B.S. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this author Boris Sokoloff M.D., Ph.D., Boris Sokoloff M.D., Ph.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaDirector.Search for more papers by this authorMichiteru Hori M.D., Michiteru Hori M.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this authorClarence C. Saelhof M.D., Ph.D., Clarence C. Saelhof M.D., Ph.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this authorTeresa Wrzolek M.D., Teresa Wrzolek M.D. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this authorTomie Imai B.S., Tomie Imai B.S. The Southern Bio-Research Institute, Florida Southern College, Lakeland, FloridaSearch for more papers by this author First published: December 1966 https://doi.org/10.1111/j.1532-5415.1966.tb02925.xCitations: 42 †Aided by grants from the National Heart Institute (HE-08505–03) and the American Heart Association, Florida Division, and its Canaveral Area Heart Association. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Keys, A.: Aging and Levels of Biological Organization. Proceedings of the Conference, Princeton, N. J., December 2–5, 1962, pp. 205–208. Chicago, Ill., Univ. of Chicago Press, 1965. 2Robinson, D. S., and French, J. E.: The heparin clearing reaction and fat transport, Quart. J. Exper. Physiol. 42, 151–163, 1957. 3Robinson, D. S.: Digestion, Absorption Intestinale et Transport des Glycerides chez les Animaux Supérieures. Paris, Editions C.N.R.S., 1961, pp. 151–156. 4Robinson, D. S.: Function of the Blood. New York, Academic Press Inc., 1961, p. 431. 5Levy, S. W.: Heparin and blood lipides, Rev. Canad. Biol. 17, 1–61, 1958. 6Albrink, M. J., and Man, E. B.: Serum triglycerides in coronary arterial disease, Arch. Int. Med. 103, 4–8, 1959. 7Barritt, D. W.: Alimentary lipaemia in men with coronary artery disease and in controls, Brit. M. J. 2, 640–644, 1956. 8Likoff, W.; Berkowitz, D.; Woldow, A.; Jacobs, A. G., and Sklaroff, D. M.: Radioactive fat absorption patterns; their significance in coronary artery atherosclerosis, Circulation 18, 1118–1123, 1958. 9Pilgeram, L. O.: Biochemical studies in relation to comparative susceptibility to experimental atherosclerosis, Fed. Proc. 14, 728–732, 1955. 10Korn, E. D.: Clearing factor, a heparin-activated lipoprotein lipase, J. Biol. Chem. 215, 1–15, 1955. 11Robinson, D. S.; Harris, P. M., and Ricketts, C. R.: Production of lipolytic activity in rat plasma after the intravenous injection of dextran sulfate, Biochem. J. 71, 286–292, 1959. 12Fraser, J. R. E.; Lovell, R. R. H., and Nestel, P. J.: The production of lipolytic activity in the human forearm in response to heparin, Clin. Sci. 20, 351–356, 1961. 13Havel, R. J.: Evidence for the participation of lipoprotein lipase in the transport of chylomicrons. Proc. Conference, Koninkl. Vlaam, Acad. Wetensch., Brussels, 1956, pp. 265–273. 14Robinson, D. S.: The clearing factor, lipase, and its action in the transport of fatty acids between the blood and the tissues, Adv. Lipid Res. 1, 133–162, 1963. 15Byers, S. O., and Friedman, M.: Site of origin of plasma triglycerides, Am. J. Physiol. 198, 629–636, 1960. 16Brown, D. F.; Heslin, A. S., and Doyle, J. T.: Postprandial lipemia in health and in ischemic heart disease, New England J. Med. 264, 733–737, 1961. 17Mitchell, J. R. A., and Bronte-Stewart, B.: Alimentary lipaemia and heparin clearing in ischaemic heart-disease, Lancet 1, 167–169, 1959. 18Bouchier, I. A. D., and Bronte-Stewart, B.: Alimentary lipaemia and ischaemic heart-disease, Lancet 1, 363–368, 1961. 19Albrink, M. J., and Man, E. B.: Serum triglycerides in health and diabetes, Diabetes 7, 194–201, 1958. 20Kagan, A.; Dawber, T. R.; Kannel, W. B., and Revotskie, N.: The Framingham study: a prospective study of coronary heart disease, Fed. Proc. 21: Suppl. 11: 52–57, 1962. 21Albrink, M. J.: Triglycerides, lipoproteins, and coronary artery disease, Arch. Int. Med. 109, 345–359, 1962. 22Kaufmann, H.: Etude clinique du facteur d'éclaircissement, Presse méd. 63: 1045, 1955. 23Nikkila, E. A., and Niemi, T.: Effect of age on the lipemia-clearing activity of serum after administration of heparin to human subjects, J. Gerontol. 12, 44–47, 1957. 24Day, A. J., and Wilkinson, G. K.: Clearing factor inhibitor in human atherosclerosis, Circulation 18, 76–81, 1958. 25Pilgeram, L. O.: Deficiencies in the lipoprotein lipase system in atherosclerosis, J. Gerontol. 13, 32–42, 1958. 26Aschoff, L.: Lectures on Pathology. New York, Paul B. Hoeber, Inc., 1924, p. 131. 27Willis, G. C.: An experimental study of the intimal ground substance in atherosclerosis, Canad. M. A. J. 69, 17–22, 1953. 28Yavorsky, M.; Almaden, P., and King, C. G.: Ascorbic acid content of atheromas, J. Biol. Chem. 106: 525, 1934. 29Becker, R. R.; Burch, H. B.; Salomon, L. L.; Venkilasubramanian, T. A., and King, C. G.: Accumulation of cholesterol in arteries in ascorbic acid deficiency. J. Am. Chem. Soc. 75, 2020–2022, 1953. 30Willis, G. C., and Fishman, S.: Ascorbic acid content of human arterial tissue, Canad. M. A. J. 72, 500–503, 1955. 31Willis, G. C.: The reversibility of atherosclerosis, Canad. M. A. J. 77, 106–109, 1957. 32Mueller, P. S., and Cardon, P. V.: Plasma free fatty acids in fasting vitamin-C-deprived guinea pigs, J. Lipid Res. 2, 83–85, 1961. 33Booker, W. M.; DaCosta, F.; Jones, W.; Froix, C., and Robinson, E.: Cholesterol-ascorbic acid relation; changes in plasma and cell ascorbic acid and plasma cholesterol following administration of ascorbic acid and cholesterol, Am. J. Physiol. 189, 75–77, 1957. 34Mendoza, A. C.: Action of ascorbic acid on blood cholesterol, Cronica Med. 72, 3–23, 1955. 35Sedov, K. R.: Prophylaxis and treatment of atherosclerosis by ascorbic acid, Terap. Arkh. 28, 58–65, 1956. 36Fedorova, E. P.: The long range treatment of coronary atherosclerosis with ascorbic acid, Soviet Med. 25, 56–60, 1960. 37Gandzha, I. M.; Kovaleva, N. I., and Bronshtein, V. N.: A comparative study of the effects of some medicinal agents in patients with atherosclerosis, Vrachebnoe Delo No. 4, 6011, 1961. 38Myasnikov, A. L.: Influence of some factors on development of experimental cholesterol atherosclerosis, Circulation 17, 99–113, 1958. 39Bavina, M. V.: Effect of ascorbic acid on hypercholesterolemia, Circulation 17, 104–106, 1958. 40Anderson, J. T.; Grande, F., and Keys, A.: Dietary ascorbic acid and serum cholesterol, Fed. Proc. 17: 468, 1958. 41Hobson, W.; Jordan, A., and Roseman, C.: Serum cholesterol levels in elderly people living at home, Lancet 2, 961–964, 1953. 42Keys, A.; Mickelsen, O.; Miller, E.; Hayes, E. R., and Todd, R. L.: The concentration of cholesterol in the blood serum of normal man and its relation to age, J. Clin. Invest. 29, 1347–1353, 1950. 43Potgieter, M.; Morse, E.; Walker, G. R., and Dayton, N. A.: Ascorbic acid and cholesterol studies on women in an institution for the handicapped, Am. J. Ment. Defic. 63, 325–329, 1958. 44Gillum, H. L.; Morgan, A. F., and Jermone, D. W.: Nutritional status of the aging, J. Nutrition 55, 449–468, 1955. 45Trier, E.: C-vitaminstudier hos syge og sunde. Copenhagen, E. Munksgaard, 1940, pp. 54–63. 46Difs, H.: Beitrage zur Diagnostik der Vitamin-C-Mangelkrankheit, Acta med. Scandinav. Suppl. 110, pp. 1–167, 1940. 47Aykroyd, W. R.; Jolliffe, N.; Lowry, O. H.; Moore, P. E.; Sebrcll, W. H.; Shank, R. E.; Tisdall, F. F.; Wilder, R. M., and Zamecnik, P. C.: Medical resurvey of nutrition in Newfoundland 1948, Canad. M. A. J. 60, 329–352, 1949. 48Kirk, J. E., and Chieffi, M.: Vitamin studies in middle-aged and old individuals. XI. The concentration of total ascorbic acid in whole blood, J. Gerontol. 8, 301–304, 1953. 49Morgan, A. F.; Gillum, H. L., and Williams, R. I.: Nutritional status of the aging. III. Serum ascorbic acid and intake, J. Nutrition 55, 431–448, 1955. 50Diehl, F., and Neumann, H.: Vitamin C-Gehalt des mensehliehc Gehirns unter besonderer Berücksichtigung der vegetativen Zentren, Klin. Wchnschr. 18, 418–422, 1939. 51Gough, J.: Vitamin C in the human pituitary, Lancet 1, 1279–1281, 1934. 52Schaus, R.: The ascorbic acid content of human pituitary, cerebral cortex, heart, and skeletal muscle and its reflation to age, Am. J. Clin. Nutrition 5, 39–41, 1957. 53Stewart, C. P.; Horn, D. B., and Robson, J. S.: The effect of cortisone and adrenocorticotropic hormone on the dehydroascorbic acid of human plasma, Biochem. J. 53, 254–261, 1953. 54Patterson, J. W.: Course of diabetes and development of cataracts after injecting dehydroascorbic acid and related substances, Am. J. Physiol. 165, 61–65, 1951. 55Lloyd, B. B., and Sinclair, H. M.: In Biochemistry and Physiology of Nutrition. New York, Academic Press Inc., 1953, vol. I, pp. 369–372. 56Patterson, J. W., and Mastin, D. W.: Some effects of dehydroascorbic acid on the central nervous system, Am. J. Physiol. 167, 119–126, 1951. 57Raiha, N.: On the placental transfer of vitamin C, Acta physiol. Scandinav. 45: Suppl. 155, 1958. 58Sokoloff, B.; Itaska, I., and Powella, R.: The cytotoxicity of ascorbone, Growth (in press). 59McGraw, J. Y., and Desmarais, A.: Study of the mechanism of action of vitamins A, P, and C on capillary resistance, Rev. Canad. Biol. 18, 133–176, 1959. 60Slusher, M. A., and Roberts, S.: Fate of adrenal ascorbic acid: relationship to corticosteroid secretion, Endocrinology 61, 98–105, 1957. 61McGraw, J. Y.: Regulation of capillary resistance effect of vitamin and hormone therapy on growth and capillary resistance in the guinea pig, Laval Med. 27, 660–710, 1959. 62Harris, L. J.; Bland, M. N.; Constable, B. J.; Howard, A., and Hughes, R. E.: Vitamin C and adrenal hormones. Abstracts, 3rd Internat. Congress Biochemistry, Brussels, 1955, p. 65. 63Khalil, H. H.: Significance of ascorbic acid in the adrenal cortex, Lancet 1, 912–914, 1954. 64Higuchi, M.: The influence of gonadotropin on ascorbic acid metabolism in aged men, Yonago Igaku Zasshi 10, 791–808, 1959. 65Ostwald, E.: Serum cholesterol level and vitamin C in geriatrics, Artztl. Praxis 11, 3–8, 1959. 66Radsma, W., and Van Groningen, H. E. M.: Catalytic action of ascorbic acid on the oxidation of fatty components in liver tissue, Acta physiol. et Pharmacol. Neerl. 8, 15–30, 1959. 67Geyer, R. P.; Hydd, S., and Ryan, M.: Fatty acid oxidation by means of ascorbic acid and oxygen, Arch. Biochem. & Biophys. 70, 129–140, 1957. 68Sokoloff, B.; Toyomizu, M.; McConnell, B.; Saelhof, C.; Trauner, W., and Domansky, G.: Experimental studies on blood hypercholesteremia in rabbits. The effect of iodine value and carbon number, J. Gerontol. 15, 19–25, 1960. 69Sokoloff, B.: Influence of iodine value, carbon number and oxidation on inhibitory activity of unsaturated fatty acids on Rous virus, Acta Unio Internat. Caner. 15, 837–881, 1959. 70Swell, L.; Flick, D. F.; Field H., Jr., and Treadwell, C. R.: Role of fats and fatty acids in absorption of dietary cholesterol, Am. J. Physiol. 180, 124–132, 1955. 71Wolff, B., and Brignon, J. J.: Recherches expérimentales sur la resorption intestinale de cholesterol chez le lapin, Bull. Soc. Chim. Biol. (Paris) 38: 99–109, 1956. 72Sokoloff, B.: The biological activity of serotonin, Growth 28, 113–126, 1964. 73Bragdon, J.: Spontaneous atherosclerosis in the rabbit, Circulation 5, 641–646, 1953. 74Banerjee, S.; Deb, C., and Belavady, B.: Effect of scurvy on glutathione and dehydroascorbic acid in guinea pig tissues, J. Biol. Chem. 195, 271–276, 1952. Citing Literature Volume14, Issue12December 1966Pages 1239-1260 ReferencesRelatedInformation